Literature DB >> 31257858

Computational Systems Pharmacology-Target Mapping for Fentanyl-Laced Cocaine Overdose.

Jin Cheng1,2, Siyi Wang1, Weiwei Lin1, Nan Wu1, Yuanqiang Wang1, Maozi Chen1, Xiang-Qun Xie1, Zhiwei Feng1.   

Abstract

The United States of America is fighting against one of its worst-ever drug crises. Over 900 people a week die from opioid- or heroin-related overdoses, while millions more suffer from opioid prescription addiction. Recently, drug overdoses caused by fentanyl-laced cocaine specifically are on the rise. Due to drug synergy and an increase in side effects, polydrug addiction can cause more risk than addiction to a single drug. In the present work, we systematically analyzed the overdose and addiction mechanism of cocaine and fentanyl. First, we applied our established chemogenomics knowledgebase and machine-learning-based methods to map out the potential and known proteins, transporters, and metabolic enzymes and the potential therapeutic target(s) for cocaine and fentanyl. Sequentially, we looked into the detail of (1) the addiction to cocaine and fentanyl by binding to the dopamine transporter and the μ opioid receptor (DAT and μOR, respectively), (2) the potential drug-drug interaction of cocaine and fentanyl via p-glycoprotein (P-gp) efflux, (3) the metabolism of cocaine and fentanyl in CYP3A4, and (4) the physiologically based pharmacokinetic (PBPK) model for two drugs and their drug-drug interaction at the absorption, distribution, metabolism, and excretion (ADME) level. Finally, we looked into the detail of JWH133, an agonist of cannabinoid 2-receptor (CB2) with potential as a therapy for cocaine and fentanyl overdose. All these results provide a better understanding of fentanyl and cocaine polydrug addiction and future drug abuse prevention.

Entities:  

Keywords:  cocaine; computational systems pharmacology-target mapping; fentanyl; fentanyl-laced cocaine; overdose; polydrug addiction

Year:  2019        PMID: 31257858      PMCID: PMC6733029          DOI: 10.1021/acschemneuro.9b00109

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  119 in total

1.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

2.  Comparative Protein Structure Modeling Using MODELLER.

Authors:  Benjamin Webb; Andrej Sali
Journal:  Curr Protoc Bioinformatics       Date:  2016-06-20

3.  Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.

Authors:  Y Yoshida; S Koide; N Hirose; K Takada; K Tomiyama; N Koshikawa; A R Cools
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

4.  CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction.

Authors:  Zheng-Xiong Xi; Rui Song; Xia Li; Guan-Yi Lu; Xiao-Qing Peng; Yi He; Guo-Hua Bi; Siyuan Peter Sheng; Hong-Ju Yang; Haiying Zhang; Jin Li; Mark Froimowitz; Eliot L Gardner
Journal:  Neuropsychopharmacology       Date:  2016-08-18       Impact factor: 7.853

5.  Alcohol and Cocaine Exposure Modulates ABCB1 and ABCG2 Transporters in Male Alcohol-Preferring Rats.

Authors:  Alaa M Hammad; Fawaz Alasmari; Youssef Sari; F Scott Hall; Amit K Tiwari
Journal:  Mol Neurobiol       Date:  2018-07-06       Impact factor: 5.590

6.  Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein.

Authors:  Christoph Wandel; Richard Kim; Margaret Wood; Alastair Wood
Journal:  Anesthesiology       Date:  2002-04       Impact factor: 7.892

7.  Effect of cocaine use on buprenorphine pharmacokinetics in humans.

Authors:  Elinore F McCance-Katz; Petrie M Rainey; David E Moody
Journal:  Am J Addict       Date:  2010 Jan-Feb

8.  Fentanyl decreases beta-CIT binding to the dopamine transporter.

Authors:  K A Bergström; J Jolkkonen; J T Kuikka; K K Akerman; H Viinamäki; O Airaksinen; E Länsimies; J Tiihonen
Journal:  Synapse       Date:  1998-08       Impact factor: 2.562

9.  GPCRdb: an information system for G protein-coupled receptors.

Authors:  Vignir Isberg; Stefan Mordalski; Christian Munk; Krzysztof Rataj; Kasper Harpsøe; Alexander S Hauser; Bas Vroling; Andrzej J Bojarski; Gert Vriend; David E Gloriam
Journal:  Nucleic Acids Res       Date:  2017-03-17       Impact factor: 16.971

10.  Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice.

Authors:  Jing-Dun Xie; Yang Huang; Dong-Tai Chen; Jia-Hao Pan; Bing-Tian Bi; Kun-Yao Feng; Wan Huang; Wei-An Zeng
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

View more
  5 in total

1.  MCCS, a novel characterization method for protein-ligand complex.

Authors:  Maozi Chen; Zhiwei Feng; Siyi Wang; Weiwei Lin; Xiang-Qun Xie
Journal:  Brief Bioinform       Date:  2021-07-20       Impact factor: 11.622

2.  IsAb: a computational protocol for antibody design.

Authors:  Tianjian Liang; Hui Chen; Jiayi Yuan; Chen Jiang; Yixuan Hao; Yuanqiang Wang; Zhiwei Feng; Xiang-Qun Xie
Journal:  Brief Bioinform       Date:  2021-09-02       Impact factor: 11.622

Review 3.  Polysubstance use in the U.S. opioid crisis.

Authors:  Wilson M Compton; Rita J Valentino; Robert L DuPont
Journal:  Mol Psychiatry       Date:  2020-11-13       Impact factor: 15.992

4.  Virus-CKB: an integrated bioinformatics platform and analysis resource for COVID-19 research.

Authors:  Zhiwei Feng; Maozi Chen; Tianjian Liang; Mingzhe Shen; Hui Chen; Xiang-Qun Xie
Journal:  Brief Bioinform       Date:  2021-03-22       Impact factor: 11.622

5.  Insight into Ginkgo biloba L. Extract on the Improved Spatial Learning and Memory by Chemogenomics Knowledgebase, Molecular Docking, Molecular Dynamics Simulation, and Bioassay Validations.

Authors:  Yan Chen; Zhiwei Feng; Mingzhe Shen; Weiwei Lin; Yuanqiang Wang; Siyi Wang; Caifeng Li; Shengfeng Wang; Maozi Chen; Weiguang Shan; Xiang-Qun Xie
Journal:  ACS Omega       Date:  2020-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.